These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 24818633

  • 1. Intensive combination treatment regimens, including prednisolone, are effective in treating patients with early rheumatoid arthritis regardless of additional etanercept: 1-year results of the COBRA-light open-label, randomised, non-inferiority trial.
    ter Wee MM, den Uyl D, Boers M, Kerstens P, Nurmohamed M, van Schaardenburg D, Voskuyl AE, Lems WF.
    Ann Rheum Dis; 2015 Jun; 74(6):1233-40. PubMed ID: 24818633
    [Abstract] [Full Text] [Related]

  • 2. A non-inferiority trial of an attenuated combination strategy ('COBRA-light') compared to the original COBRA strategy: clinical results after 26 weeks.
    den Uyl D, ter Wee M, Boers M, Kerstens P, Voskuyl A, Nurmohamed M, Raterman H, van Schaardenburg D, van Dillen N, Dijkmans B, Lems W.
    Ann Rheum Dis; 2014 Jun; 73(6):1071-8. PubMed ID: 23606682
    [Abstract] [Full Text] [Related]

  • 3. Initial high-dose prednisolone combination therapy using COBRA and COBRA-light in early rheumatoid arthritis.
    Rasch LA, van Tuyl LH, Lems WF, Boers M.
    Neuroimmunomodulation; 2015 Jun; 22(1-2):51-6. PubMed ID: 25227967
    [Abstract] [Full Text] [Related]

  • 4. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention.
    Landewé RB, Boers M, Verhoeven AC, Westhovens R, van de Laar MA, Markusse HM, van Denderen JC, Westedt ML, Peeters AJ, Dijkmans BA, Jacobs P, Boonen A, van der Heijde DM, van der Linden S.
    Arthritis Rheum; 2002 Feb; 46(2):347-56. PubMed ID: 11840436
    [Abstract] [Full Text] [Related]

  • 5. Indirect and total costs of early rheumatoid arthritis: a randomized comparison of combined step-down prednisolone, methotrexate, and sulfasalazine with sulfasalazine alone.
    Korthals-de Bos I, Van Tulder M, Boers M, Verhoeven AC, Adèr HJ, Bibo J, Boonen A, Van Der Linden S.
    J Rheumatol; 2004 Sep; 31(9):1709-16. PubMed ID: 15338488
    [Abstract] [Full Text] [Related]

  • 6. Why are Dutch rheumatologists reluctant to use the COBRA treatment strategy in early rheumatoid arthritis?
    van Tuyl LH, Plass AM, Lems WF, Voskuyl AE, Dijkmans BA, Boers M.
    Ann Rheum Dis; 2007 Jul; 66(7):974-6. PubMed ID: 17392349
    [Abstract] [Full Text] [Related]

  • 7. Therapies for active rheumatoid arthritis after methotrexate failure.
    O'Dell JR, Mikuls TR, Taylor TH, Ahluwalia V, Brophy M, Warren SR, Lew RA, Cannella AC, Kunkel G, Phibbs CS, Anis AH, Leatherman S, Keystone E, CSP 551 RACAT Investigators.
    N Engl J Med; 2013 Jul 25; 369(4):307-18. PubMed ID: 23755969
    [Abstract] [Full Text] [Related]

  • 8. Long-term effects on bone mineral density after four years of treatment with two intensive combination strategies, including initially high-dose prednisolone, in early rheumatoid arthritis patients: the COBRA-light trial.
    Lucassen MJJ, Ter Wee MM, den Uyl D, Konijn NPC, Nurmohamed MT, Voskuyl AE, van Schaardenburg D, Kerstens PJSM, Bultink IEM, Boers M, Lems WF.
    Osteoporos Int; 2021 Jul 25; 32(7):1441-1449. PubMed ID: 33464392
    [Abstract] [Full Text] [Related]

  • 9. Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial.
    Verschueren P, De Cock D, Corluy L, Joos R, Langenaken C, Taelman V, Raeman F, Ravelingien I, Vandevyvere K, Lenaerts J, Geens E, Geusens P, Vanhoof J, Durnez A, Remans J, Vander Cruyssen B, Van Essche E, Sileghem A, De Brabanter G, Joly J, Meyfroidt S, Van der Elst K, Westhovens R.
    Ann Rheum Dis; 2015 Jan 25; 74(1):27-34. PubMed ID: 25359382
    [Abstract] [Full Text] [Related]

  • 10. Meta-analysis suggests that intensive non-biological combination therapy with step-down prednisolone (COBRA strategy) may also 'disconnect' disease activity and damage in rheumatoid arthritis.
    Boers M, van Tuyl L, van den Broek M, Kostense PJ, Allaart CF.
    Ann Rheum Dis; 2013 Mar 25; 72(3):406-9. PubMed ID: 23155223
    [Abstract] [Full Text] [Related]

  • 11. Similar efficacy and safety of initial COBRA-light and COBRA therapy in rheumatoid arthritis: 4-year results from the COBRA-light trial.
    Konijn NPC, van Tuyl LHD, Boers M, den Uyl D, Ter Wee MM, van der Wijden LKM, Bultink IEM, Kerstens PJSM, Voskuyl AE, van Schaardenburg D, Nurmohamed MT, Lems WF.
    Rheumatology (Oxford); 2017 Sep 01; 56(9):1586-1596. PubMed ID: 28859326
    [Abstract] [Full Text] [Related]

  • 12. Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial.
    van der Heijde D, Klareskog L, Singh A, Tornero J, Melo-Gomes J, Codreanu C, Pedersen R, Freundlich B, Fatenejad S.
    Ann Rheum Dis; 2006 Mar 01; 65(3):328-34. PubMed ID: 16079172
    [Abstract] [Full Text] [Related]

  • 13. Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study).
    Leirisalo-Repo M, Kautiainen H, Laasonen L, Korpela M, Kauppi MJ, Kaipiainen-Seppänen O, Luosujärvi R, Luukkainen R, Karjalainen A, Blåfield H, Uutela T, Ilva K, Julkunen HA, Paimela L, Puolakka K, Moilanen E, Hannonen PJ, Möttönen T, NEO-RACo Study Group.
    Ann Rheum Dis; 2013 Jun 01; 72(6):851-7. PubMed ID: 22753402
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.
    Klareskog L, van der Heijde D, de Jager JP, Gough A, Kalden J, Malaise M, Martín Mola E, Pavelka K, Sany J, Settas L, Wajdula J, Pedersen R, Fatenejad S, Sanda M, TEMPO (Trial of Etanercept and Methotrexate with Radiographic Patient Outcomes) study investigators.
    Lancet; 2004 Feb 28; 363(9410):675-81. PubMed ID: 15001324
    [Abstract] [Full Text] [Related]

  • 15. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy.
    van der Heijde D, Burmester G, Melo-Gomes J, Codreanu C, Mola EM, Pedersen R, Freundlich B, Chang DJ, Etanercept Study 400 Investigators.
    Ann Rheum Dis; 2008 Feb 28; 67(2):182-8. PubMed ID: 17728331
    [Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness and cost-utility of combination therapy in early rheumatoid arthritis: randomized comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone. COBRA Trial Group. Combinatietherapie Bij Reumatoïde Artritis.
    Verhoeven AC, Bibo JC, Boers M, Engel GL, van der Linden S.
    Br J Rheumatol; 1998 Oct 28; 37(10):1102-9. PubMed ID: 9825750
    [Abstract] [Full Text] [Related]

  • 17. Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90% remission in a pilot trial.
    van Tuyl LH, Lems WF, Voskuyl AE, Kerstens PJ, Garnero P, Dijkmans BA, Boers M.
    Ann Rheum Dis; 2008 Nov 28; 67(11):1574-7. PubMed ID: 18625629
    [Abstract] [Full Text] [Related]

  • 18. Survival, comorbidities and joint damage 11 years after the COBRA combination therapy trial in early rheumatoid arthritis.
    van Tuyl LH, Boers M, Lems WF, Landewé RB, Han H, van der Linden S, van de Laar M, Westhovens R, van Denderen JC, Westedt ML, Peeters AJ, Jacobs P, Huizinga TW, van de Brink H, Dijkmans BA, Voskuyl AE.
    Ann Rheum Dis; 2010 May 28; 69(5):807-12. PubMed ID: 19451137
    [Abstract] [Full Text] [Related]

  • 19. A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial.
    Moreland LW, O'Dell JR, Paulus HE, Curtis JR, Bathon JM, St Clair EW, Bridges SL, Zhang J, McVie T, Howard G, van der Heijde D, Cofield SS, TEAR Investigators.
    Arthritis Rheum; 2012 Sep 28; 64(9):2824-35. PubMed ID: 22508468
    [Abstract] [Full Text] [Related]

  • 20. Open-label observation of addition of etanercept versus a conventional disease-modifying antirheumatic drug in subjects with active rheumatoid arthritis despite methotrexate therapy in the Latin American region.
    Machado DA, Guzman RM, Xavier RM, Simon JA, Mele L, Pedersen R, Ferdousi T, Koenig AS, Kotak S, Vlahos B.
    J Clin Rheumatol; 2014 Jan 28; 20(1):25-33. PubMed ID: 24356474
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.